The non-invasive REVITATM procedure is currently being investigated by Imperial College London as part of a clinical trial (called DOMINO) to investigate whether duodenal mucosal resurfacing (DMR) can increase insulin sensitivity and help women of reproductive age start menstruating.
The ground-breaking procedure does not involve any form of surgery, neither does it require participants to take any form of medication to lower their sugar and no device is left in the patient, so it is minimally invasive, and means recovery time is relatively quick. However, if successful, the results will have a substantial impact on millions of women around the world.
To ensure the success of the trial, Imperial College London actively wanted to raise awareness of the study, increase the number of participants taking part, and highlight how this trial could significantly improve the lives of PCOS patients and reduce the cost of PCOS to the NHS.
You have done a great job with this trial and this has had a very positive impact on our recruitment. Thank you for your great work.